191 related articles for article (PubMed ID: 37067605)
1. Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry.
Heibloem RE; Komen MMC; Ilozumba OUC; van den Hurk CJG
Support Care Cancer; 2023 Apr; 31(5):273. PubMed ID: 37067605
[TBL] [Abstract][Full Text] [Related]
2. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Nieboer P; van der Hoeven JJM; Smorenburg CH
Support Care Cancer; 2019 May; 27(5):1919-1925. PubMed ID: 30206728
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
[TBL] [Abstract][Full Text] [Related]
4. Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.
Lugtenberg RT; van den Hurk CJG; Smorenburg CH; Mosch L; Houtsma D; Deursen MAGDH; Kaptein AA; Gelderblom H; Kroep JR
Support Care Cancer; 2022 Aug; 30(8):6641-6648. PubMed ID: 35501515
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of increasing the scalp cooling duration to prevent alopecia during adjuvant chemotherapy for breast cancer: a randomized pilot study.
Carton E; Blas AM; Perret C; Le Bihan M
Support Care Cancer; 2024 Jun; 32(7):410. PubMed ID: 38839667
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel.
Macduff C; Mackenzie T; Hutcheon A; Melville L; Archibald H
Eur J Cancer Care (Engl); 2003 Jun; 12(2):154-61. PubMed ID: 12787013
[TBL] [Abstract][Full Text] [Related]
7. Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia.
Orlando L; Loparco D; Fedele P; Schiavone P; Quaranta A; Caliolo C; Cinefra M; Rizzo P; Calvani N; Morleo A; Varriano R; Bonuso V; Falcone LL; Caloro M; Cinieri S
Future Oncol; 2019 Oct; 15(29):3337-3344. PubMed ID: 31578891
[No Abstract] [Full Text] [Related]
8. Scalp cooling in breast cancer patients treated with docetaxel-cyclophosphamide: patient- and nurse-reported results.
Coolbrandt A; T'Jonck A; Blauwens K; Dejaeger E; Neven P; Punie K; Vancoille K; Wildiers H
Breast Cancer Res Treat; 2021 Apr; 186(3):715-722. PubMed ID: 33452953
[TBL] [Abstract][Full Text] [Related]
9. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry.
van den Hurk CJ; Peerbooms M; van de Poll-Franse LV; Nortier JW; Coebergh JW; Breed WP
Acta Oncol; 2012 Apr; 51(4):497-504. PubMed ID: 22304489
[TBL] [Abstract][Full Text] [Related]
10. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
Giarratano T; Frezzini S; Zanocco M; Giorgi CA; Mioranza E; Miglietta F; Griguolo G; Falci C; Faggioni G; Tasca G; Di Liso E; Vernaci G; Menichetti A; Mantiero M; Grosso D; Guarneri V; Dieci MV
Breast J; 2020 Jul; 26(7):1296-1301. PubMed ID: 31837103
[TBL] [Abstract][Full Text] [Related]
11. Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients.
Fujii T; Ichiba K; Honda C; Tokuda S; Nakazawa Y; Ogino M; Kurozumi S; Obayashi S; Yajima R; Shirabe K
Breast Cancer; 2021 Mar; 28(2):329-334. PubMed ID: 32944881
[TBL] [Abstract][Full Text] [Related]
12. Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
Carbognin L; Accetta C; Di Giorgio D; Fuso P; Muratore M; Tiberi G; Pavese F; D'Angelo T; Fabi A; Giannarelli D; Di Leone A; Magno S; Garganese G; Sanchez AM; Terribile DA; Franceschini G; Masetti R; Scambia G; Paris I
Curr Oncol; 2022 Sep; 29(10):7218-7228. PubMed ID: 36290846
[TBL] [Abstract][Full Text] [Related]
13. Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.
Komen MM; Breed WP; Smorenburg CH; van der Ploeg T; Goey SH; van der Hoeven JJ; Nortier JW; van den Hurk CJ
Support Care Cancer; 2016 Jun; 24(6):2735-41. PubMed ID: 26805558
[TBL] [Abstract][Full Text] [Related]
14. Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients.
Kluger N; Jacot W; Frouin E; Rigau V; Poujol S; Dereure O; Guillot B; Romieu G; Bessis D
Ann Oncol; 2012 Nov; 23(11):2879-2884. PubMed ID: 22571858
[TBL] [Abstract][Full Text] [Related]
15. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
[TBL] [Abstract][Full Text] [Related]
16. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
[TBL] [Abstract][Full Text] [Related]
17. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
Eur J Oncol Nurs; 2013 Oct; 17(5):536-40. PubMed ID: 23571182
[TBL] [Abstract][Full Text] [Related]
18. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
[TBL] [Abstract][Full Text] [Related]
19. Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature.
Komen MMC; Smorenburg CH; Nortier JWR; van der Ploeg T; van den Hurk CJG; van der Hoeven JJM
Breast; 2016 Dec; 30():105-110. PubMed ID: 27689316
[TBL] [Abstract][Full Text] [Related]
20. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients.
Ridderheim M; Bjurberg M; Gustavsson A
Support Care Cancer; 2003 Jun; 11(6):371-7. PubMed ID: 12768403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
